Ibisobanuro
Methyl 2-cyanoisonicotinate ni isuku ryinshi, yuzuye neza yujuje ibyangombwa bisabwa kugirango sintezike yibiyobyabwenge.Ubwiza bwayo buhebuje kandi buhoraho bituma igira uruhare rukomeye mu masosiyete yimiti n’ibigo by’ubushakashatsi bikora ku iterambere n’umusaruro wa topirastat.
Uru ruganda rwagati nurufunguzo rwo gutangira ibintu muri synthesis ya topirastat.Binyuze muburyo bwitondewe bwimiti itanga umusaruro wanyuma wa farumasi.Kubwibyo, isuku, ituze, hamwe nubwizerwe bwa methyl 2-cyanoisonicotinate nibyingenzi kugirango hamenyekane ubuziranenge nubushobozi bwibicuruzwa byanyuma.
Methyl 2-cyanoisonicotinate ikorwa hifashishijwe inzira zigezweho hamwe nibikoresho bigezweho kugirango tumenye neza kandi byiza.Ikora igeragezwa nisesengura rikomeye kugirango irebe ko yujuje ubuziranenge bwashyizweho n’inganda zimiti.Nkigisubizo, abakiriya bacu barashobora kwigirira ikizere mubwizerwa no guhuzagurika kwuru ruganda rwingenzi.
Hitamo
JDK ifite ibikoresho byo mu rwego rwa mbere n’ibikoresho byo gucunga ubuziranenge, byizeza itangwa rihamye ry’abahuza API.Itsinda ryumwuga ryizeza R&D yibicuruzwa.Kurwanya byombi, turimo gushakisha CMO & CDMO kumasoko yimbere mu gihugu no mumahanga.
